Delivery Order SPE2DB20D6037-SPE2DB22FD0JZ

Award Date 9/23/22
Potential Completion Date 9/26/22
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,049.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4563933480 - Dextroamphetamine-Amphetamine 10 mg capsules in 100 count packages. The award is not associated with a set-aside designation. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,070.32 firm fixed-price contract is for the delivery of 4,563,354,156 units of the drug dextroamphetamine-amphetamine 20 mg tablets in 100-count bottles. This order is placed under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,581.84 firm fixed-price contract is for the delivery of 4,566,225,721 units of dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of October 28, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,530.05 firm fixed-price contract is for the delivery of 4,558,698,205 dextroamphetamine-amphetamine 5 mg tablets to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 7, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery...
This is a $1,408.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dextroamphetamine-Amphetamine 20 mg capsules in 100-count bottles. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,000.98 contract is for the delivery of 4,567,329,296 lisdexamfetamine 20 mg capsules, and has an ultimate completion date of February 21, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for 4,564,043,713 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, to be delivered by March 22, 2024. The order has a ceiling value of $2,077.40 and does not have a set-aside designation. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for $2,097.52. The order is for Dextroamphetamine-Amphetamine 25 mg capsules, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB22FD0JZ
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,526.78 award is for the delivery of 4,558,579,566 units of the prescription drug Dextroamphetamine-Amphetamine 20 mg Capsules.

The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. As a prime vendor for the DLA's Medical Supply Chain division, DMS Pharmaceutical Group supplies a variety of medications, including branded and generic drugs, biologics, and medical consumables, to Department of Defense (DoD) and Department of Veterans Affairs (VA) medical centers. This particular award does not have a set-aside designation.

Generated 10/23/24, 9:22 AM